Clinical Trial Update: RN624 In Adult Patients With Chronic Low Back Pain [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for RN624 in adults with chronic low back pain; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• RN624

Snippet

Sponsor: Pfizer | Conditions: Low Back Pain | Phase 2 | Status: COMPLETED | Results posted: 2021-06-16